Rimonabant - Acomplia® - Zimulti® - Information

Disclaimer: The medication here is a registered trademarks of Sanofi-Aventis (Acomplia Zimulti). We are not associated or affiliated with them in any way. Any information found here is provided for general informational purposes only and is not meant to substitute for the advice provided by your own physician or other medical professional. You should not use any of the information found here to diagnose or treat a health issue or disease or to prescribe any medication. Always seek medical advice from a medical doctor. Please Read Entire Disclaimer.

Sanofi-Synthelabo, a French Pharmaceutical Company created Rimonabant (Acomplia® and possibly Zimulti) which is a new drug treatment for obesity and possibly other ailments. This diet pill was officially approved in Britain on June 28th 2006. It has also be approved in several other European countries and other countries around the world. Which could someday lead the way to having the FDA approve it for the United States. But no guarantees, The FDA has strick policies regarding new medications on the market. And it recently did not approve it for the USA.

Acomplia (Rimonabant or Zimulti) diet pills offer hope for obese individuals. Especially where other treatments had little affect or whose side effects where too much to handle. This medication (as any) obviously does not come without some potential side effects for its user but could offer more that others. Rimonabant works differently than other weightloss pills, and has other potential benefits than any other diet drug. Studies also show that it increases levels of HDL (good cholesterol) while at the same time reducing the triglycerides (bad cholesterol). It could also possibly be used as a smoking cessation although not officially approved as one (yet).

Please Note the FDA has Not approved Rimonabant (Acomplia® Zimulti®) for use in the USA.
If you are from the USA proceed here. Be sure to read the disclaimer and follow all local laws regarding this medication. If you wish to inquire about this medication, see the following.

Basically put, Rimonabant has been shown to suppress ones appetite. It works by blocking a cellular receptor in the endocannabinoid system of the brain, believed to influence the regulation of body weight, glucose and lipid metabolism. In doing so it is believed that this regulation then reduces the craving to eat more.

Clinical Studies have shown that 33% of people taking Rimonabant lost 10% of body weight and kept their weight down for two years which is extremely newsworthy as no other diet drug has accomplished this for so long a period. It also holds huge potential for the obese individual who also wants to kick the smoking habit apparently also help out in cocaine, marijuana and alcohol additions.